arrow
H

Hitoshi Hashimoto

institute for open and transdisciplinary research initiatives
H指数:66
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neonatal oxytocin administration restores impaired ultrasonic vocalizations in a mouse model of 3q29 deletion syndrome

新生小鼠催产素给药恢复了3q29缺失综合征小鼠模型中受损的超声波发声

2026-08-210
OAAI
Astrocyte-vascular interactions are disturbed in cerebral white matter of adult-onset neuronal intranuclear inclusion disease

成年发病型神经元核内包涵体病的脑白质中,星形胶质细胞-血管相互作用受到干扰。

2026-02-060
OA
Neuron-specific overexpression of human vasoactive intestinal peptide receptor 2 in mice causes cognitive dysfunction and abnormal dendritic morphology in the prefrontal cortex

在小鼠中特异性过表达人血管活性肠肽受体2会导致认知功能障碍和前额叶皮质异常的树突形态。

2025-12-160
OAAI
Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models

垂体腺苷酸环化酶激活多肽受体拮抗剂PA-915在慢性应激小鼠模型中表现出快速且持久的抗抑郁样作用。

2025-09-040
OAAI
(R)-KETAMINE AMELIORATES DEPRESSION-LIKE BEHAVIORS AND COGNITIVE IMPAIRMENT VIA ACTIVATION OF THE ANTERIOR INSULAR CORTEX IN SOCIAL ISOLATION-REARED MICE

(R)-氯胺酮通过激活前岛叶皮层,改善社会隔离饲养小鼠的抑郁样行为和认知功能障碍

2025-02-120
OA
TREATMENT FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG NORMALIZES AIS LENGTH ABNORMALITY ALONG WITH HYPERACTIVITY IN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)-DEFICIENT MICE

治疗注意缺陷多动障碍(ADHD)的药物通过 normalize AIS 长度异常,并伴随垂体腺苷酸环化酶激活多肽(PACAP)缺乏小鼠的高活动性。

2025-02-120
OA
OVEREXPRESSION OF VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2 IN NEURONS CAUSES ABNORMAL DENDRITIC MORPHOLOGY IN THE PREFRONTAL CORTEX AND COGNITIVE IMPAIRMENT

血管活性肠肽受体2在神经元中的过度表达导致前额叶皮层树突形态异常和认知障碍

2025-02-120
OA
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

大规模动物模型研究发现大脑pH和乳酸水平的改变是涉及认知障碍的神经精神障碍的诊断内表型

2024-03-266
OAAI